CMED China Medical Technologies ADS, Each Representing 10 Ordinary Shares (MM)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment)

NAME OF ISSUER China Medical Tech-Spon ADR

TITLE OF CLASS OF SECURITIES Common

CUSIP NUMBER 169483104

The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Page 1 of 9 Pages

13G

 5. Sole Voting Power

 390
Number of shares) -----------------------------
Beneficially ) 6. Shared Voting Power
owned by each )
 NONE
Reporting )
Person with: ) -----------------------------
 7. Sole Dispositive Power

 2608258
 -----------------------------
 8. Shared Dispositive Power

 NONE
------------------------------------------------------------------------------
9. Aggregate amount beneficially owned by each reporting person

 2608258

13G

NONE

Number of shares) -----------------------------
Beneficially ) 6. Shared Voting Power
Owned by each )
Reporting ) NONE
Person with: ) -----------------------------
 7. Sole Dispositive Power

 2510040
 -----------------------------
 8. Shared Dispositive Power

 NONE
------------------------------------------------------------------------------
9. Aggregate amount beneficially owned by each reporting person

 2510040
------------------------------------------------------------------------------

10. Check box if the aggregate amount in row (9) excludes certain shares*

13G

 5. Sole Voting Power

 390
Number of shares) -----------------------------
Beneficially ) 6. Shared Voting Power
Owned by each )
Reporting ) NONE
Person with: ) -----------------------------
 7. Sole Dispositive Power

 98218
 -----------------------------
 8. Shared Dispositive Power

 NONE
------------------------------------------------------------------------------
9. Aggregate amount beneficially owned by each reporting person

 98218
------------------------------------------------------------------------------

10. Check box if the aggregate amount in row (9) excludes certain shares*

SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. 1)

Item 1(a) Name of Issuer: China Medical Tech-Spon ADR

Item 1(b) Address of Issuer's Principal Executive Offices:

No. 24 Yong Chang North Road, Beijing Economic-Technological Development Area, Beijing 100176, People's Republic of China

Item 2(a) Item 2(b)

Name of Person Filing: Address or Principal Office or, if
 NONE, Residence:

Putnam Investments, LLC d/b/a Putnam One Post Office Square
Investments ("PI") Boston, Massachusetts 02109
on behalf of itself and:

Putnam Investment Management, LLC. One Post Office Square
 ("PIM") Boston, Massachusetts 02109

The Putnam Advisory Company, LLC. One Post Office Square
 ("PAC") Boston, Massachusetts 02109

Item 2(c) Citizenship: PI, PIM and PAC are limited liability companies
organized under Delaware law. The citizenship of other persons identified in Item 2(a) is designated as follows:

** Voluntary association known as Massachusetts business trust - Massachusetts law

Item 2(d) Title of Class of Securities: Common

Item 2(e) Cusip Number: 169483104

Page 5 of 9 Pages

Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b),
check whether the person filing is a:

(a)( ) Broker or Dealer registered under Section 15 of the Act

(b)( ) Bank as defined in Section 3(a)(6) of the Act

(c)( ) Insurance Company as defined in Section 3(a)(19) of the Act

(d)( ) Investment Company registered under Section 8 of the Investment Company Act

(e)( X ) Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940

(f)( ) Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund; see (Section 240.13d-1(b)(1)(ii)(F)

(g)( X ) Parent Holding Company, in accordance with Section 240.13d-1(b)(ii)(G)

(h)( ) Group, in accordance with Section 240.13d-1(b)(1)(ii)(H)

Page 6 of 9 Pages

Item 4.
Ownership.
 PIM* PAC PI
 ----- --- ----
 (Investment advisers (Parent company
 & subsidiaries of PI) to PIM and PAC)

(a) Amount Beneficially
 Owned: 2510040 + 98218 = 2608258

(b) Percent of Class: 7.6% + 0.3% = 7.9%

(c) Number of shares as
 to which such person has:

(1) sole power to vote
 or to direct the vote;
 (but see Item 7) NONE 390 390

(2) shared power to vote
 or to direct the vote;
 (but see Item 7) NONE NONE NONE

(3) sole power to dispose
 or to direct the
 disposition of;
 (but see Item 7) ALL ALL ALL

(4) shared power to
 dispose or to direct
 the disposition of;
 (but see Item 7) NONE NONE NONE



Page 7 of 9 Pages

Item 5. Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date thereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ( )

Item 6. Ownership of More than Five/Ten Percent on Behalf of Another
Person:
No persons other than the persons filing this Schedule 13G have an economic interest in the securities reported on which relates to more than five percent of the class of securities. Securities reported on this Schedule 13G as being beneficially owned by PI consist of securities beneficially owned by subsidiaries of PI which are registered investment advisers, which in turn include securities beneficially owned by clients of such investment advisers, which clients may include investment companies registered under the Investment Company Act and/or employee benefit plans, pension funds, endowment funds or other institutional clients.

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

PI, wholly owns two registered investment advisers: Putnam Investment Management, LLC., which is the investment adviser to the Putnam family of mutual funds and The Putnam Advisory Company, LLC., which is the investment adviser to Putnam's institutional clients. Both subsidiaries have dispository power over the shares as investment managers, but each of the mutual fund's trustees have voting power over the shares held by each fund, and The Putnam Advisory Company, LLC has shared voting power over the shares held by the institutional clients. Pursuant to Rule 13d-4, PI declares that the filing of this Schedule 13G shall not be deemed an admission for the purposes of Section 13(d) or 13(g) that it is the beneficial owner of any securities covered by this Schedule 13G, and further states that it does not have any power to vote or dispose of, or direct the voting or disposition of, any of the securities covered by this Schedule 13G.

Item 8. Identification and Classification of Members of the Group:
Not applicable.

Item 9. Notice of Dissolution of Group:

Not applicable.

Item 10. Certification.

Page 8 of 9 Pages

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business, were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

PUTNAM INVESTMENTS, LLC.

 /s/ Harold P. Short Jr.
BY: -------------------------------------------
 Signature

Name/Title: Harold P. Short Jr.
Director of Trade Oversight and International Compliance

Date: February 14, 2012

For this and all future filings, reference is made to Power of Attorney dated February 15, 2011, with respect to duly authorized signatures on behalf of Putnam Investments, LLC., Putnam Investment Management, LLC., The Putnam Advisory Company, LLC. and any Putnam Fund wherever applicable.

For this and all future filings, reference is made to an Agreement dated June 28, 1990, with respect to one filing of Schedule 13G on behalf of said entities, pursuant to Rule 13d-1(f)(1).

Page 9 of 9 Pages

China Medical (NASDAQ:CMED)
Historical Stock Chart
From Mar 2024 to Apr 2024

China Medical (NASDAQ:CMED)
Historical Stock Chart
From Apr 2023 to Apr 2024